ARTICLE | Clinical News

Enbrel regulatory update

November 9, 2016 10:01 PM UTC

FDA approved an sBLA for Enbrel etanercept from Amgen to treat chronic moderate to severe plaque psoriasis in patients ages 4-17 who are candidates for systemic therapy or phototherapy. Enbrel is appr...

BCIQ Company Profiles

Amgen Inc.